Molecular Markers for Breast Cancer: Prediction on Tumor BehaviorBruna Karina Banin Hirata, Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda et al.|Disease Markers|2014Cited by 185
Regulatory T cells and breast cancer: implications for immunopathogenesisMaria Angélica Ehara Watanabe, Júlio César Voltarelli, Julie Massayo Maeda Oda et al.|Cancer and Metastasis Reviews|2010Cited by 120
Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseasesJulie Massayo Maeda Oda, Maria Angélica Ehara Watanabe, Bruna Karina Banin Hirata et al.|Journal of Genetics|2013Cited by 106
CC Chemokine Receptor 5: The Interface of Host Immunity and CancerCarlos Eduardo Coral de Oliveira, Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda et al.|Disease Markers|2014Cited by 65
CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non‐hodgkin's lymphomaKaren Brajão de Oliveira, Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda et al.|Journal of Clinical Laboratory Analysis|2009Cited by 42